Literature DB >> 6588974

Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various necrotizing agents in rats.

F Ueda, S Aratani, K Mimura, K Kimura, A Nomura, H Enomoto.   

Abstract

The effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on the gastric mucosal damage induced in rats by various necrotizing agents was compared with those of cimetidine, cetraxate and prostaglandin (PG) E2. MN-1695 at doses of 0.37 mg (1 mumol) to 3.72 mg (10 mumol)/kg, significantly decreased in a dose-dependent manner the damage indices after the application of ethanol, HCl, NaOH, 25% NaCl or boiling water. Cimetidine in doses of 12.6 mg (50 mumol) to 126 mg (500 mumol)/kg was effective only against HCl-induced damage. Cetraxate in doses of 34.2 mg (100 mumol) to 342 mg (1 mmol)/kg was effective against damage due to ethanol, HCl, 25% NaCl or boiling water. However, cetraxate increased the damage index of NaOH-induced injury. PGE2 in a dose of 25 micrograms (70 nmol)/kg was effective against ethanol and 25% NaCl. The histological changes of gastric mucosal cells produced by ethanol were significantly decreased by MN-1695 and PGE2. These results suggest that MN-1695 has a cytoprotective action like that of PGE2 and that this cytoprotection inhibits the development of various kinds of experimental gastric ulcers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6588974

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

Review 1.  Gastric cytoprotection: a critical appraisal of the concept, methodology, implications, mechanisms and future research prospects.

Authors:  N S Parmar; M Tariq; A M Ageel
Journal:  Agents Actions       Date:  1987-10

2.  Protective effect of Irsogladine on monochloramine induced gastric mucosal lesions in rats:a comparative study with rebamipide.

Authors:  H Yamamoto; M Umeda; H Mizoguchi; S Kato; K Takeuchi
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

3.  Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice.

Authors:  Y Mizoguchi; N Kawada; Y Ichikawa; K Kobayashi; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1991-04

4.  Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.

Authors:  Hana Yamaguchi; Kenji Suzuki; Masaki Nagata; Tomoyuki Kawase; Vijayakumar Sukumaran; Rajarajan A Thandavarayan; Yusuke Kawauchi; Junji Yokoyama; Masayuki Tomita; Hiroshi Kawachi; Kenichi Watanabe; Hiroyuki Yoneyama; Hitoshi Asakura; Ritsuo Takagi
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

5.  Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.

Authors:  Kohei Kamei; Yoshikazu Kubo; Naho Kato; Ryo Hatazawa; Kikuko Amagase; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

6.  Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.

Authors:  Xin Zhang; Koyuki Tajima; Kiyoto Kageyama; Takashi Kyoi
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

7.  Triazine derivatives inhibit rat hepatocarcinogenesis but do not enhance gap junctional intercellular communication.

Authors:  T Hori; M Asamoto; V Krutovskikh; Y Iwahori; M Maeda; H Toriyama-Baba; N Takasuka; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1997-01

Review 8.  Regulation of defensive function on gingival epithelial cells can prevent periodontal disease.

Authors:  Tsuyoshi Fujita; Tetsuya Yoshimoto; Mikihito Kajiya; Kazuhisa Ouhara; Shinji Matsuda; Tasuku Takemura; Keiichi Akutagawa; Katsuhiro Takeda; Noriyoshi Mizuno; Hidemi Kurihara
Journal:  Jpn Dent Sci Rev       Date:  2017-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.